4hlw

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "4hlw" [edit=sysop:move=sysop])
Line 3: Line 3:
The entry 4hlw is ON HOLD
The entry 4hlw is ON HOLD
-
Authors: M Ravi Shashi Nayana, Leblanc, E, Axerio-Cilies, P, Labriere, C, Frewin, K, Hassona, M.D.H, Lack, N.A., Han, F.Q., Guns,E.S., Young, R., Ban, F, Rennie, P.S., Cherkasov, A.
+
Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.
Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.
Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.

Revision as of 13:23, 8 November 2012

Unreleased structure

The entry 4hlw is ON HOLD

Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.

Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools